Assura Past Earnings Performance

Past criteria checks 1/6

Assura's earnings have been declining at an average annual rate of -36.4%, while the Health Care REITs industry saw earnings declining at 0.2% annually. Revenues have been growing at an average rate of 8.9% per year. Assura's return on equity is 4.1%, and it has net margins of 40.2%.

Key information

-36.4%

Earnings growth rate

-38.1%

EPS growth rate

Health Care REITs Industry Growth7.7%
Revenue growth rate8.9%
Return on equity4.1%
Net Margin40.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Assura makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:AGRl Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2416466140
30 Jun 2416119140
31 Mar 24158-29140
31 Dec 23155-98140
30 Sep 23153-168140
30 Jun 23152-144140
31 Mar 23150-119140
31 Dec 22148-1130
30 Sep 22146117130
30 Jun 22142137130
31 Mar 22137156120
31 Dec 21133145110
30 Sep 21128134100
30 Jun 21125121110
31 Mar 21121108120
31 Dec 2011897120
30 Sep 2011686130
30 Jun 2011483120
31 Mar 2011279100
31 Dec 1911081100
30 Sep 1910883100
30 Jun 191058490
31 Mar 191028490
31 Dec 18996090
30 Sep 18963690
30 Jun 18915480
31 Mar 18867280
31 Dec 17819980
30 Sep 177612780
30 Jun 177411170
31 Mar 17719570
31 Dec 16696570
30 Sep 16663470
30 Jun 16643170
31 Mar 16612880
31 Dec 15594280
30 Sep 15575680
30 Jun 15544770
31 Mar 15513760
30 Sep 14452860
30 Jun 14422660
31 Mar 14402460

Quality Earnings: AGRl has a large one-off loss of £37.5M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: AGRl became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AGRl's earnings have declined by 36.4% per year over the past 5 years.

Accelerating Growth: AGRl has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: AGRl has become profitable in the last year, making it difficult to compare its past year earnings growth to the Health Care REITs industry (29.2%).


Return on Equity

High ROE: AGRl's Return on Equity (4.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 10:31
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Assura Plc is covered by 20 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kanad MitraBarclays
Miranda CockburnBerenberg
Tom HorneBerenberg